ACE and obesity due to melanocortin 4 receptor deficiency: As activation of the RAAS system is one of the main ways in which obesity contributes to elevated BP and hypertension, it follows that angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) would be appropriate initial agents in the treatment of obesity-related hypertension.